Guidance from the Working Group:
Using Liquid Biopsy in Advanced NSCLC
The Advantages of Liquid Biopsy for NSCLC Treatment
Liquid Biopsy: Confidence in the Concordance Data
Actionable information based on a demonstrated concordance between cell-free DNA and tissue.
Treat Sooner with Liquid Biopsy
Obtain information in half-the-time, regardless of tissue availability.
Avoid the Challenges with Tissue Biopsies
Mitigating demonstrated limitations of tissue availability to test for all NCCN recommended biomarkers at first line.
The Actionability of Liquid Biopsy Results
Understanding the value of liquid biopsy reports in the presence and absence of driver mutations.
Liquid Biopsy Before First Line
Ensuring every advanced NSCLC patient gets the right targeted therapy first.